Cardinal Health, Inc. (CAH)
| Market Cap | 35.35B |
| Revenue (ttm) | 222.58B |
| Net Income (ttm) | 1.56B |
| Shares Out | 238.68M |
| EPS (ttm) | 6.45 |
| PE Ratio | 22.96 |
| Forward PE | 15.77 |
| Dividend | $2.04 (1.38%) |
| Ex-Dividend Date | Jul 1, 2025 |
| Volume | 3,478,303 |
| Open | 147.63 |
| Previous Close | 146.30 |
| Day's Range | 145.47 - 148.76 |
| 52-Week Range | 100.80 - 168.44 |
| Beta | 0.68 |
| Analysts | Buy |
| Price Target | 159.00 (+7.35%) |
| Earnings Date | Aug 12, 2025 |
About CAH
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products.... [Read more]
Financial Performance
In 2025, Cardinal Health's revenue was $222.58 billion, a decrease of -1.87% compared to the previous year's $226.83 billion. Earnings were $1.56 billion, an increase of 83.22%.
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for CAH stock is "Buy." The 12-month stock price target is $159.0, which is an increase of 7.35% from the latest price.
News
Cardinal Health to Extend Reach by Acquiring Solaris Health
Cardinal Health's multi-specialty management services organization (MSO), The Specialty Alliance, plans to acquire urology MSO Solaris Health. Cardinal Health will enable the acquisition by providing ...
Top Stock Movers Now: Hanesbrands, On Holding, Cardinal Health, and More
U.S. equities gained at midday after the latest report on consumer inflation came in lower than expected, boosting hopes of a Federal Reserve rate cut. The Nasdaq and S&P 500 traded at record highs, a...
Cardinal Health, Inc. (CAH) Q4 2025 Earnings Call Transcript
Cardinal Health, Inc. (NYSE:CAH) Q4 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Company Participants Aaron E. Alt - Chief Financial Officer Jason M.
Cardinal Health Stock Tumbles on Earnings and $1.9 Billion Solaris Health Purchase
The company will acquire Solaris Health, a urology management services organization, for around $1.9 billion in cash.
Cardinal Health Reports Fourth Quarter and Fiscal Year 2025 Results and Raises Fiscal Year 2026 Guidance
Fourth quarter revenue was relatively flat at $60.2 billion; revenue increased 21% excluding the impact of a previously communicated contract expiration Fourth quarter GAAP1 operating earnings were $4...
Cardinal Health to buy Solaris Health for $1.9 billion
Drug distributor Cardinal Health said on Tuesday it would acquire Solaris Health for about $1.9 billion in cash.
Cardinal Health announces the addition of Solaris Health, the country's leading urology MSO, to The Specialty Alliance
Adds over 750 providers to Cardinal Health's multi-specialty MSO platform, The Specialty Alliance Joins with recent urology acquisitions to bolster The Specialty Alliance's leadership in the urology t...
Cardinal Health Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Cardinal Health, Inc. CAH will release earnings results for the fourth quarter before the opening bell on Tuesday, Aug. 12.
Cardinal Health Q4 Preview: Accelerating Autoimmune, Urology And Oncology, Buy
Initiating Cardinal Health, Inc. with a Buy rating and $239 fair value, driven by specialty distribution growth and successful GMPD turnaround. Specialty segments in autoimmune, urology, and oncology ...
How To Earn $500 A Month From Cardinal Health Stock Ahead Of Q4 Earnings
Cardinal Health, Inc. CAH will release earnings results for the fourth quarter before the opening bell on Tuesday, Aug. 12.
Cardinal Health Foundation expands Equity Rx to increase access to prescription medications, bringing total investment to $5M
Grant funds will also launch the development of Ohio's first statewide prescription drug repository DUBLIN, Ohio , July 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today the expansio...
Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2025 on August 12
DUBLIN, Ohio , July 15, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2025 on August 12, prior to the opening of t...
Cardinal Health announces One Voice Initiative to support independent pharmacy advocacy
DUBLIN, Ohio , July 11, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced the launch of the Cardinal Health™ One Voice Initiative for pharmacy advocacy, which provides direct financial ...
Best Dividend Aristocrats For July 2025
Dividend Aristocrats have underperformed the S&P 500 in 2025, with NOBL up 1.77% versus SPY's 5.55% year-to-date gain. Dividend growth remains healthy, with 44 out of 69 Aristocrats already raising pa...
CAH CFO on Pharmaceutical Distributor's Outlook
Aaron Alt, CFO at Cardinal Health (CAH), joins Diane King Hall at the NYSE set to discuss the company's financial outlook. He describes the drugmaker's share buyback plans and recent FY25 guidance rai...
Cardinal Health raises annual profit target
Drug distributor Cardinal Health raised its annual adjusted profit forecast on Thursday, banking on demand for costly specialty medicines and branded drugs at its pharmaceuticals unit.
Cardinal Health Details Momentum and Updated Long-Term Value Creation Plans at Investor Day
Key announcements: Raising FY25 non-GAAP diluted EPS guidance to $8.15 to $8.20 1 Establishing preliminary FY26 non-GAAP diluted EPS guidance of $9.10 to $9.30 (13% growth at the mid-points)2 Confirmi...
Cardinal Health Analyst Flags Fading Scale Gap, Sees Rising Edge in Specialty Growth
BofA Securities analyst Allen Lutz reiterated the Buy rating on Cardinal Health, Inc. CAH, raising the price forecast from $165 to $170.
Cramer's Stop Trading: Cardinal Health
Jim Cramer breaks down why he's keeping an eye on shares of Cardinal Health.
Cardinal Health launches new medical device for the continuous monitoring of three essential vital signs in one system
Kendall DL™ Multi System simplifies patient monitoring, drives efficiencies for providers DUBLIN, Ohio , June 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the U.S. launch of it...
Best Dividend Aristocrats For June 2025
Dividend Aristocrats have slightly outperformed the S&P 500 year-to-date, despite underperforming in April and May. Dividend growth remains robust, with 41 of 69 Aristocrats announcing increases in 20...
Cardinal Health releases new report on the cell and gene therapy industry
Analysis charts the emergence and future of advanced therapies DUBLIN, Ohio , May 7, 2025 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its 2025 Advanced Therapies Report: Revolutionizin...
Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio , May 5, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5107 per share, out of the Comp...